Related Experiment Video

Updated: Jun 20, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene

Sylvie Larrat1, Patrice Morand, Ariane Bas

  • 1UMI 3265, UJF-EMBL-CNRS, Unit of Virus Host Cell Interactions, Grenoble, France.

Antiviral Therapy
|August 26, 2009
PubMed
Abstract

Insights

Small interfering RNA (siRNA) effectively targets Epstein-Barr virus (EBV) protease (PR) mRNA, significantly reducing viral replication and infectious particle production. This demonstrates siRNA

Area of Science:

  • Virology
  • Molecular Biology
  • RNA Interference

Background:

  • Epstein-Barr virus (EBV) protease (PR) is vital for viral replication.
  • EBV PR is a potential target for antiviral therapies.
  • No prior studies investigated siRNA inhibition of EBV PR mRNA.

Purpose of the Study:

  • To investigate the efficacy of siRNA in inhibiting EBV protease (PR) expression and replication.
  • To assess the role of EBV PR in infectious particle production.

Main Methods:

  • Utilized 293 cells with stable EBV episomes.
  • Delivered siRNAs targeting EBV PR.
  • Quantified EBV DNA, PR mRNA, and protein levels.
  • Measured infectious EBV particle production via Raji cell superinfection.

Main Results:

  • EBV PR mRNA reduced by 73%.
  • EBV PR protein levels decreased by 35%.
  • Viral production in supernatant reduced by 86-95%.

Conclusions:

  • siRNA targeting EBV PR significantly inhibits viral replication.
  • EBV PR plays a critical role in infectious particle formation.
  • Targeting EBV PR with siRNA presents a novel therapeutic strategy for EBV-associated diseases.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...